Initiation of Intrathecal Drug Delivery Dramatically Reduces Systemic Opioid Use in Patients With Advanced Cancer
ConclusionsIn the largest cohort of patients with advanced cancer and refractory pain treated with IDDS, implantation was associated with a dramatic reduction in systemic opioid use 30 days postoperatively, with a large majority of patients discontinuing systemic opioids. Those patients that continued systemic opioids utilized significantly lower doses as compared to their pre‐implant dose.
Source: Neuromodulation: Technology at the Neural Interface - Category: Biotechnology Authors: Jill E. Sindt,
Daniel W. Odell,
Andrew P. Dalley,
Shane E. Brogan Tags: Clinical Research Source Type: research
More News: Biotechnology | Brain | Cancer | Cancer & Oncology | Morphine | Neurology | Oral Cancer | Pain